Page last updated: 2024-10-15

cysteine sulfinic acid and Amyotrophic Lateral Sclerosis

cysteine sulfinic acid has been researched along with Amyotrophic Lateral Sclerosis in 2 studies

cysteine sulfinic acid: metabolite of sulfur-containing amino acids

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, N1
Nakano, M1
Kato, S1
Yoshihara, D1
Ookawara, T1
Eguchi, H1
Taniguchi, N1
Suzuki, K1
Tsunoda, M1

Other Studies

2 other studies available for cysteine sulfinic acid and Amyotrophic Lateral Sclerosis

ArticleYear
Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase.
    The Journal of biological chemistry, 2007, Dec-07, Volume: 282, Issue:49

    Topics: Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Cysteine; Humans; Hydrogen Peroxide; Lewy

2007
[Changes in cysteine sulfinic acid in rat brain under the experimental elevation of taurine content].
    Rinsho shinkeigaku = Clinical neurology, 1996, Volume: 36, Issue:5

    Topics: Amyotrophic Lateral Sclerosis; Animals; Brain; Chromatography, High Pressure Liquid; Cysteine; Excit

1996